Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

CapEx to Depreciation

0.29×

Quarterly · Period ending:

LCTX logo

LCTX CapEx to Depreciation

Latest reported0.29×
LCTX Quarterly CapEx/Depreciation (0.00× → 0.29×)
High-resolution chart · PNG

LCTX capex to depreciation history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock CapEx to Depreciation — Quarterly
Period endingCapEx to Depreciation
0.2941×
0.2926×
0.5968×
0.0674×
0.0819×
0.5915×
2.4172×
0.7943×
0.3521×
0.2171×
0.52×
0.7898×
1.5059×
1.0994×
0.0925×
1.4819×
0.5301×
0.2584×
0.7644×
0.3417×
0.5838×
0.0385×
0.0714×
0.0535×
0.011×
0.0141×
0.0095×
0.0907×
0.2597×
0.2241×
1.3656×
1.5329×
0.0453×
1.1564×
0.4605×
0.5487×
0.3418×
0.2506×
0.4697×
0.5342×
0.6261×
0.4877×
0.6126×
0.9639×
1.5669×
0.2368×
0.004×
0.0564×
0.1057×
0.1427×
0.1876×
1.5339×
0.3055×
0.6563×
0.2491×
0.0697×
0.054×
0.1867×
0.375×
0.3381×
0.3735×
0.5702×
0.495×
0.0962×
0.7378×
23.9685×
2.7465×
3.0198×
0.6988×
0.4004×
102.0787×
-2.0418×
3.1107×
0.0276×
-0.0222×
0×
0×
0.2304×
-0.0588×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
0×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.